• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE Back to Search Results
Model Number GIF-HQ190
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature article: "endoscopic ultrasound-guided drainage of patients with infected walled-off necrosis: which stent to choose?" literature summary: this single-center retrospective study of a prospectively collected database of all symptomatic pancreatic fluid collection (pfc) patients who underwent eus-guided drainage.Among 120 patients with pfc (108 walled-off necrosis (won), 22 pseudocyst) who underwent eus-guided drainage, there was no difference in outcome parameters in biflanged metal stents (bfms) and double pigtail plastic stents (dpps) groups.Among patients with won, clinical success was significantly higher (96.2% vs.81.8%, p=0.04), with significantly shorter hospital stay (6 vs.10 d) and procedure duration (17.18 ± 4.6 vs.43.6 ± 9.7 min, p<.0001) in the bfms group.Among patients with infected won with/without organ failure (of), the clinical success was significantly higher (100% vs.73.9%) in bfms compared with dpps group.The duration of the procedure was significantly lower (16.28 ± 4.4 vs.44.39 ± 10.7, p<.0001) in bfms compared with dpps group this study concluded that eus-guided drainage of won using bfms scores over dpps.In patients having infected won with/without of, bfms may be preferred over dpps.Type of adverse events/number of patients: [dpps] (n = 60), bleed - 4 patients, perforation - 1 patient, stent migration - 1 patient, recurrence of collection - 2 patients, mortality - 2 patients.[bfms] (n = 60), bleed - 1 patient, stent migration - 2 patients, recurrence of collection - 1 patient.For the "ez shot3 plus" described in the literature, we selected the "na-u200h-8019" with the largest number of shipments in the region and during the study period, and created etq.Since there is no olympus device called "uct 180", "gf-uct180" was selected.From the above, 6 complaints were created because the literature includes patient deaths.(b)(6): na-u200h-8019(for death of patients).(b)(6): na-u200h-8019(for adverse events other than death).(b)(6): gf-uct180 (for death of patients).(b)(6): gf-uct180 (for adverse events other than death).(b)(6): gif-hq190 (for death of patients).(b)(6): gif-hq190 (for adverse events other than death).This complaint is (b)(6).
 
Manufacturer Narrative
This report is being supplemented to provide additional information received from the authoring physician and the legal manufacturer's final investigation.B5: updated with information received from the authoring physician.The device history record (dhr) for the complaint devices could not be reviewed since the serial numbers were not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the author said that an olympus device did not cause or contribute to any of the patient adverse events and death described in this literature.In addition, the malfunction of the device has not been reported, and from clinical/medical evaluation and risk assessment, it is likely that the reported event is an accident or a complication associated with a surgical procedure using the subject device.A definitive root cause cannot be identified.Olympus will continue to monitor the field performance of this device.
 
Event Description
The authoring physician confirmed the olympus device did not cause or contribute to the adverse events reported in the article.The device is not available to return.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE
Type of Device
GASTROINTESTINAL VIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer Contact
masaharu hirose
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8-520
JA   965-8520
426422891
MDR Report Key15491828
MDR Text Key300647822
Report Number9610595-2022-02280
Device Sequence Number1
Product Code FDS
UDI-Device Identifier04953170305276
UDI-Public04953170305276
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K131780
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGIF-HQ190
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/29/2022
Initial Date FDA Received09/27/2022
Supplement Dates Manufacturer Received11/11/2022
Supplement Dates FDA Received11/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
UNK LOT/SERIAL: NA-U200H-8019, GF-UCT180
Patient Outcome(s) Other;
-
-